10:29 ET -- Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The pharmaceutical company reported fourth-quarter sales of $11.41 billion, lower than $11.99 billion in the prior-year period, but higher than expectations of $11.19 billion from analysts polled by FactSet. Profit came out at $2.02 billion, or 95 cents a share, below last year's $2.37 billion in profit, or $1.07 a share, and analyst expectations of $2.26 billion in profit or $0.82 a share. Earnings on an adjusted basis were $1.82 a share, above analyst expectations of $1.73. Dow Jones & Co. owns Factiva. (ada.hui@wsj.com)

(END) Dow Jones Newswires

February 02, 2023 10:44 ET (15:44 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb Charts.